Skip to content

Application Effects of Remimazolam and Propofol on Elderly Patients Undergoing Hip Replacement

Application Effects of Remimazolam and Propofol on Elderly Patients Undergoing Hip Replacement

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055214
Enrollment
Unknown
Registered
2022-01-03
Start date
2021-04-20
Completion date
Unknown
Last updated
2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia for elderly patients

Interventions

Remimazolam Group:given intravenous injection of 0.2-0.4 mg/kg of remimazolam during induction
Propofol Group:selected 1.5-2 mg/kg of propofol during induction

Sponsors

Hefei Second People's Hospital, Anhui Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Presence of hip destruction confirmed by X-ray or CT imaging; conforming to indications for hip replacement determined by Chinese Medical Association Orthopaedic Society: (1) Ineffective conservative treatment of hip osteoarthritis; (2) Obviously limited joint function affecting life; (3) Femoral head collapse in femoral head necrosis due to a variety of reasons; (4) Displaced femoral neck fractures in the elderly and femoral neck fractures with failed internal fixation); 2. Hip replacement for the first time; 3. Ability to communicate independently; 4. Aged >= 60 years.

Exclusion criteria

Exclusion criteria: 1. Involved heart, brain, kidney and hematopoietic dysfunctions; 2. Previous history of severe mental illness or delirium; 3. History of Alzheimer s disease or epilepsy; 4. Previous history of coronary heart disease, hypertension or diabetes mellitus.

Design outcomes

Primary

MeasureTime frame
Circulation index (mean arterial pressure);Stress index (plasma adrenaline);cognitive function;

Secondary

MeasureTime frame
Analgesic effect;Anesthesia effect (extubation time);General information (height and weight);

Countries

China

Contacts

Public ContactXin Wang

Hefei Second People's Hospital, Anhui Province

anaesthes@126.com+86 13956089142

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026